In 2025, the scholarly journal Brain Conflux was officially recognized by receiving its International Standard Serial Number (ISSN) 3079-6016

To further support responsible research assessment practices, Brain Conflux has taken steps to publicly expand the range of available journal and article metrics...

Prior to submitting your manuscript to Brain Conflux, it's essential to understand the various metrics used to evaluate journals and individual articles...

The citation impact measures the frequency with which the average article in a journal has been cited in a particular year or period...

• 2028 CiteScore (Scopus): >10
• 2028 Journal Citation Indicator (Clarivate): >4
• 2028 Journal Impact Factor (Clarivate): >20

Article usage statistics provide insight into the popularity and accessibility of publications...

• 2028 Full Text Views: >300000

The efficiency of the editorial and peer review processes is critical for researchers who seek timely feedback on their submissions...

• 2025 Acceptance rate: 21%
• 2025 Submission to first decision: 19 days
• 2025 Submission to acceptance: 52 days

Brain Conflux aspires to be a leading journal in the fields of life sciences and medical research, publishing high-quality original research, review articles, brief reports, and commentaries. Our mission is to advance interdisciplinary frontiers, promote the translation of basic scientific discoveries into clinical practice, and accelerate the transformation of research outcomes into practical healthcare solutions. Brain Conflux provides an open-access platform for global researchers, clinicians, and professionals to share and discuss cutting-edge findings and technologies.

At its core, Brain Conflux aims to integrate a broad spectrum of life sciences and medicine, emphasizing the importance of interdisciplinary collaboration. We encourage researchers to explore connections between different disciplines, propose innovative research ideas, and translate these concepts into practical applications that can directly impact human health. Through this approach, we not only seek to enhance academic knowledge but also aim to make a significant and lasting contribution to improving public health.

To ensure the quality and impact of published content, Brain Conflux implements a rigorous peer-review system. All submitted manuscripts undergo a swift yet transparent review process by experts in the field. We are committed to minimizing the time from submission to publication while maintaining high academic standards. Additionally, we place great emphasis on research ethics and data integrity, requiring authors to adhere to internationally recognized publication guidelines.

As an open-access journal, Brain Conflux ensures that all published articles are freely available for reading and downloading worldwide. This model not only facilitates the widespread dissemination of knowledge but also enhances the societal value of research outcomes. By removing access barriers, we aim to foster more academic exchanges and collaborations, thereby advancing the entire research community.

Brain Conflux welcomes submissions from around the globe, particularly those that reflect regional characteristics or address global challenges. We recognize that research activities in different cultural contexts offer unique perspectives and methodologies. Therefore, we actively encourage diverse contributions, inviting researchers from both developed and developing countries to participate in building a more inclusive and equitable academic environment.

Beyond academic excellence, Brain Conflux takes on significant social responsibilities. We aim to help policymakers better understand the nature of current health issues by providing scientific evidence for effective interventions. Additionally, we strive to increase public awareness of the importance of life sciences and garner broader support for research endeavors.

With rapid advancements in science and technology, new research directions continually emerge. Brain Conflux especially encourages submissions in emerging fields such as gene editing, AI-assisted diagnostics, personalized medicine, and more. We believe these cutting-edge technologies will revolutionize future medicine, and we aim to expedite their development and application through this platform.